NCT06732375 Pilot Study of Mindset Moments Among Adolescent and Young Adult Cancer Survivors
| NCT ID | NCT06732375 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-06-13 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-06-13 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the feasibility and acceptability of the Mindset Moments™ (MM™) program in managing psychological distress and resiliency in adolescent and young adult cancer survivors. Study participation will involve attending 8 weekly, one hour, live online group sessions and completing daily 5 minute activities such as guided imageries and CBT check in within the app. Participants will also be asked to complete an online survey at the time of enrollment and at 4 and 8 weeks.
Eligibility Criteria
Inclusion Criteria: * 19-25 years of age * Prior AYA cancer diagnosis * Completed primary treatment for their cancer * Score of 3 or above on the Distress Thermometer at the time of recruitment Exclusion Criteria: * Individuals without legal capacity to give consent * Individuals who are not fluent in reading, writing, and speaking English
Contact & Investigator
Sophia K Smith, PhD, MSW
PRINCIPAL INVESTIGATOR
Duke University
Frequently Asked Questions
Who can join the NCT06732375 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, up to 25 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06732375 currently recruiting?
Yes, NCT06732375 is actively recruiting participants. Contact the research team at andrea.pires@duke.edu for enrollment information.
Where is the NCT06732375 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT06732375 clinical trial?
NCT06732375 is sponsored by Duke University. The principal investigator is Sophia K Smith, PhD, MSW at Duke University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.